Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,327 | N/A | N/A | N/A | N/A |
| Marketable Securities | 7,323 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 6,770 | 6,190 |
| TOTAL | $22,224 | $N/A | $N/A | $6,770 | $6,190 |
| Non-Current Assets | |||||
| PPE Net | 961 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 719 | 0 | 0 | 12,250 | 10,340 |
| TOTAL | $1,680 | $N/A | $N/A | $12,250 | $10,340 |
| Total Assets | $23,904 | $N/A | $N/A | $19,020 | $16,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,636 | 0 | 0 | 5,030 | 7,840 |
| Accrued Expenses | 3,314 | N/A | N/A | 15,440 | 18,140 |
| Other current liabilities | N/A | N/A | N/A | 22,580 | 2,570 |
| TOTAL | $4,950 | $N/A | $N/A | $108,410 | $28,550 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 553 | 0 | 0 | 1,380 | 66,740 |
| TOTAL | $630 | $N/A | $N/A | $16,100 | $66,740 |
| Total Liabilities | $5,580 | $N/A | $N/A | $124,510 | $95,290 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 70 | 70 |
| Retained earnings | -91,862 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 108,978 | 0 | 0 | -2,790 | -2,350 |
| TOTAL | $18,324 | $N/A | $N/A | $1,083,090 | $1,080,430 |
| Total Liabilities And Equity | $23,904 | $0 | $0 | $1,207,600 | $1,175,720 |